Thirdly, our study is the first to suggest that the improvement of cognitive dysfunction in T2DM rats by PCSK9 inhibitors may be associated with increased expression of Ttr in hippocampal tissue. This evidence concerns the gene PCSK9 and type 2 diabetes mellitus.